<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d99">
    <sentence id="DDI-DrugBank.d99.s0" text="Drugs Metabolized by P450 2D6 - The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7-10% of caucasians are so called poor metabolizers);"/>
    <sentence id="DDI-DrugBank.d99.s1" text="reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."/>
    <sentence id="DDI-DrugBank.d99.s2" text="Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.">
        <entity id="DDI-DrugBank.d99.s2.e0" charOffset="69-93"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s2.e1" charOffset="96-99"
            type="group" text="TCAs"/>
        <pair id="DDI-DrugBank.d99.s2.p0" e1="DDI-DrugBank.d99.s2.e0"
            e2="DDI-DrugBank.d99.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s3" text="Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA).">
        <entity id="DDI-DrugBank.d99.s3.e0" charOffset="163-165"
            type="group" text="TCA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s4" text="In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."/>
    <sentence id="DDI-DrugBank.d99.s5" text="An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.">
        <entity id="DDI-DrugBank.d99.s5.e0" charOffset="47-49"
            type="group" text="TCA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s6" text="The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine;">
        <entity id="DDI-DrugBank.d99.s6.e0" charOffset="96-104"
            type="drug" text="quinidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s7" text="cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).">
        <entity id="DDI-DrugBank.d99.s7.e0" charOffset="0-9" type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d99.s7.e1" charOffset="66-80"
            type="group" text="antidepressants"/>
        <entity id="DDI-DrugBank.d99.s7.e2" charOffset="83-96"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d99.s7.e3" charOffset="107-129"
            type="group" text="Type 1C antiarrhythmics"/>
        <entity id="DDI-DrugBank.d99.s7.e4" charOffset="131-141"
            type="drug" text="propafenone"/>
        <entity id="DDI-DrugBank.d99.s7.e5" charOffset="147-156"
            type="drug" text="flecainide"/>
        <pair id="DDI-DrugBank.d99.s7.p0" e1="DDI-DrugBank.d99.s7.e0"
            e2="DDI-DrugBank.d99.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p1" e1="DDI-DrugBank.d99.s7.e0"
            e2="DDI-DrugBank.d99.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p2" e1="DDI-DrugBank.d99.s7.e0"
            e2="DDI-DrugBank.d99.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p3" e1="DDI-DrugBank.d99.s7.e0"
            e2="DDI-DrugBank.d99.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p4" e1="DDI-DrugBank.d99.s7.e0"
            e2="DDI-DrugBank.d99.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p5" e1="DDI-DrugBank.d99.s7.e1"
            e2="DDI-DrugBank.d99.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p6" e1="DDI-DrugBank.d99.s7.e1"
            e2="DDI-DrugBank.d99.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p7" e1="DDI-DrugBank.d99.s7.e1"
            e2="DDI-DrugBank.d99.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p8" e1="DDI-DrugBank.d99.s7.e1"
            e2="DDI-DrugBank.d99.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p9" e1="DDI-DrugBank.d99.s7.e2"
            e2="DDI-DrugBank.d99.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p10" e1="DDI-DrugBank.d99.s7.e2"
            e2="DDI-DrugBank.d99.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p11" e1="DDI-DrugBank.d99.s7.e2"
            e2="DDI-DrugBank.d99.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p12" e1="DDI-DrugBank.d99.s7.e3"
            e2="DDI-DrugBank.d99.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p13" e1="DDI-DrugBank.d99.s7.e3"
            e2="DDI-DrugBank.d99.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s7.p14" e1="DDI-DrugBank.d99.s7.e4"
            e2="DDI-DrugBank.d99.s7.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s8" text="While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.">
        <entity id="DDI-DrugBank.d99.s8.e0" charOffset="24-52"
            type="group" text="serotonin reuptake inhibitors"/>
        <entity id="DDI-DrugBank.d99.s8.e1" charOffset="55-59"
            type="group" text="SSRIs"/>
        <entity id="DDI-DrugBank.d99.s8.e2" charOffset="69-78"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d99.s8.e3" charOffset="81-90"
            type="drug" text="sertraline"/>
        <entity id="DDI-DrugBank.d99.s8.e4" charOffset="97-106"
            type="drug" text="paroxetine"/>
        <pair id="DDI-DrugBank.d99.s8.p0" e1="DDI-DrugBank.d99.s8.e0"
            e2="DDI-DrugBank.d99.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p1" e1="DDI-DrugBank.d99.s8.e0"
            e2="DDI-DrugBank.d99.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p2" e1="DDI-DrugBank.d99.s8.e0"
            e2="DDI-DrugBank.d99.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p3" e1="DDI-DrugBank.d99.s8.e0"
            e2="DDI-DrugBank.d99.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p4" e1="DDI-DrugBank.d99.s8.e1"
            e2="DDI-DrugBank.d99.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p5" e1="DDI-DrugBank.d99.s8.e1"
            e2="DDI-DrugBank.d99.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p6" e1="DDI-DrugBank.d99.s8.e1"
            e2="DDI-DrugBank.d99.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p7" e1="DDI-DrugBank.d99.s8.e2"
            e2="DDI-DrugBank.d99.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p8" e1="DDI-DrugBank.d99.s8.e2"
            e2="DDI-DrugBank.d99.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s8.p9" e1="DDI-DrugBank.d99.s8.e3"
            e2="DDI-DrugBank.d99.s8.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s9" text="The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.">
        <entity id="DDI-DrugBank.d99.s9.e0" charOffset="20-23"
            type="group" text="SSRI"/>
        <entity id="DDI-DrugBank.d99.s9.e1" charOffset="25-27"
            type="group" text="TCA"/>
        <entity id="DDI-DrugBank.d99.s9.e2" charOffset="141-144"
            type="group" text="SSRI"/>
        <pair id="DDI-DrugBank.d99.s9.p0" e1="DDI-DrugBank.d99.s9.e0"
            e2="DDI-DrugBank.d99.s9.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d99.s9.p1" e1="DDI-DrugBank.d99.s9.e0"
            e2="DDI-DrugBank.d99.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s9.p2" e1="DDI-DrugBank.d99.s9.e1"
            e2="DDI-DrugBank.d99.s9.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s10" text="Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other.">
        <entity id="DDI-DrugBank.d99.s10.e0" charOffset="62-65"
            type="group" text="TCAs"/>
        <entity id="DDI-DrugBank.d99.s10.e1" charOffset="83-87"
            type="group" text="SSRIs"/>
        <pair id="DDI-DrugBank.d99.s10.p0" e1="DDI-DrugBank.d99.s10.e0"
            e2="DDI-DrugBank.d99.s10.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s11" text="Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).">
        <entity id="DDI-DrugBank.d99.s11.e0" charOffset="120-129"
            type="drug" text="fluoxetine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s12" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.">
        <entity id="DDI-DrugBank.d99.s12.e0" charOffset="19-43"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s12.e1" charOffset="156-179"
            type="group" text="tricyclic antidepressant"/>
        <pair id="DDI-DrugBank.d99.s12.p0" e1="DDI-DrugBank.d99.s12.e0"
            e2="DDI-DrugBank.d99.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s13" text="Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required.">
        <entity id="DDI-DrugBank.d99.s13.e0" charOffset="98-121"
            type="drug" text="tricyclic antidepressant"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s14" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be coadministered with another drug known to be an inhibitor of P450 2D6.">
        <entity id="DDI-DrugBank.d99.s14.e0" charOffset="27-29"
            type="group" text="TCA"/>
        <entity id="DDI-DrugBank.d99.s14.e1" charOffset="56-58"
            type="group" text="TCA"/>
        <pair id="DDI-DrugBank.d99.s14.p0" e1="DDI-DrugBank.d99.s14.e0"
            e2="DDI-DrugBank.d99.s14.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s15" text="Monoamine Oxidase Inhibitors: Guanethidine or similarly acting compounds;">
        <entity id="DDI-DrugBank.d99.s15.e0" charOffset="0-27"
            type="drug" text="Monoamine Oxidase Inhibitors"/>
        <entity id="DDI-DrugBank.d99.s15.e1" charOffset="30-41"
            type="drug" text="Guanethidine"/>
        <pair id="DDI-DrugBank.d99.s15.p0" e1="DDI-DrugBank.d99.s15.e0"
            e2="DDI-DrugBank.d99.s15.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s16" text="thyroid medication;">
        <entity id="DDI-DrugBank.d99.s16.e0" charOffset="0-6"
            type="drug" text="thyroid"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s17" text="alcohol, barbiturates and other CNS depressants;">
        <entity id="DDI-DrugBank.d99.s17.e0" charOffset="0-6"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d99.s17.e1" charOffset="9-20"
            type="drug" text="barbiturates"/>
        <entity id="DDI-DrugBank.d99.s17.e2" charOffset="32-46"
            type="drug" text="CNS depressants"/>
        <pair id="DDI-DrugBank.d99.s17.p0" e1="DDI-DrugBank.d99.s17.e0"
            e2="DDI-DrugBank.d99.s17.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s17.p1" e1="DDI-DrugBank.d99.s17.e0"
            e2="DDI-DrugBank.d99.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s17.p2" e1="DDI-DrugBank.d99.s17.e1"
            e2="DDI-DrugBank.d99.s17.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s18" text="and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.">
        <entity id="DDI-DrugBank.d99.s18.e0" charOffset="4-13"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d99.s18.e1" charOffset="20-36"
            type="drug" text="amitriptyline HCl"/>
        <entity id="DDI-DrugBank.d99.s18.e2" charOffset="52-66"
            type="drug" text="anticholinergic"/>
        <entity id="DDI-DrugBank.d99.s18.e3" charOffset="78-92"
            type="drug" text="sympathomimetic"/>
        <entity id="DDI-DrugBank.d99.s18.e4" charOffset="111-121"
            type="drug" text="epinephrine"/>
        <entity id="DDI-DrugBank.d99.s18.e5" charOffset="143-153"
            type="drug" text="anesthetics"/>
        <pair id="DDI-DrugBank.d99.s18.p0" e1="DDI-DrugBank.d99.s18.e0"
            e2="DDI-DrugBank.d99.s18.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p1" e1="DDI-DrugBank.d99.s18.e0"
            e2="DDI-DrugBank.d99.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p2" e1="DDI-DrugBank.d99.s18.e0"
            e2="DDI-DrugBank.d99.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p3" e1="DDI-DrugBank.d99.s18.e0"
            e2="DDI-DrugBank.d99.s18.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p4" e1="DDI-DrugBank.d99.s18.e0"
            e2="DDI-DrugBank.d99.s18.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p5" e1="DDI-DrugBank.d99.s18.e1"
            e2="DDI-DrugBank.d99.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p6" e1="DDI-DrugBank.d99.s18.e1"
            e2="DDI-DrugBank.d99.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p7" e1="DDI-DrugBank.d99.s18.e1"
            e2="DDI-DrugBank.d99.s18.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p8" e1="DDI-DrugBank.d99.s18.e1"
            e2="DDI-DrugBank.d99.s18.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p9" e1="DDI-DrugBank.d99.s18.e2"
            e2="DDI-DrugBank.d99.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p10" e1="DDI-DrugBank.d99.s18.e2"
            e2="DDI-DrugBank.d99.s18.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p11" e1="DDI-DrugBank.d99.s18.e2"
            e2="DDI-DrugBank.d99.s18.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p12" e1="DDI-DrugBank.d99.s18.e3"
            e2="DDI-DrugBank.d99.s18.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p13" e1="DDI-DrugBank.d99.s18.e3"
            e2="DDI-DrugBank.d99.s18.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s18.p14" e1="DDI-DrugBank.d99.s18.e4"
            e2="DDI-DrugBank.d99.s18.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s19" text="Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.">
        <entity id="DDI-DrugBank.d99.s19.e0" charOffset="36-52"
            type="drug" text="amitriptyline HCl"/>
        <entity id="DDI-DrugBank.d99.s19.e1" charOffset="75-89"
            type="drug" text="anticholinergic"/>
        <entity id="DDI-DrugBank.d99.s19.e2" charOffset="106-116"
            type="drug" text="neuroleptic"/>
        <pair id="DDI-DrugBank.d99.s19.p0" e1="DDI-DrugBank.d99.s19.e0"
            e2="DDI-DrugBank.d99.s19.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d99.s19.p1" e1="DDI-DrugBank.d99.s19.e0"
            e2="DDI-DrugBank.d99.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s19.p2" e1="DDI-DrugBank.d99.s19.e1"
            e2="DDI-DrugBank.d99.s19.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s20" text="Paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic-type drugs.">
        <entity id="DDI-DrugBank.d99.s20.e0" charOffset="45-69"
            type="drug" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s20.e1" charOffset="91-105"
            type="drug" text="anticholinergic"/>
        <pair id="DDI-DrugBank.d99.s20.p0" e1="DDI-DrugBank.d99.s20.e0"
            e2="DDI-DrugBank.d99.s20.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s21" text="Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs.">
        <entity id="DDI-DrugBank.d99.s21.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d99.s21.e1" charOffset="63-87"
            type="drug" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s21.e2" charOffset="171-175"
            type="drug" text="drugs"/>
        <pair id="DDI-DrugBank.d99.s21.p0" e1="DDI-DrugBank.d99.s21.e0"
            e2="DDI-DrugBank.d99.s21.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d99.s21.p1" e1="DDI-DrugBank.d99.s21.e0"
            e2="DDI-DrugBank.d99.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s21.p2" e1="DDI-DrugBank.d99.s21.e1"
            e2="DDI-DrugBank.d99.s21.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s22" text="Clinically significant effects have been reported with the tricyclic antidepressants when used concomitantly with cimetidine.">
        <entity id="DDI-DrugBank.d99.s22.e0" charOffset="59-83"
            type="drug" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s22.e1" charOffset="114-123"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d99.s22.p0" e1="DDI-DrugBank.d99.s22.e0"
            e2="DDI-DrugBank.d99.s22.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s23" text="Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.">
        <entity id="DDI-DrugBank.d99.s23.e0" charOffset="30-54"
            type="drug" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s23.e1" charOffset="121-135"
            type="drug" text="anticholinergic"/>
        <entity id="DDI-DrugBank.d99.s23.e2" charOffset="162-171"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d99.s23.e3" charOffset="190-193"
            type="drug" text="drug"/>
        <pair id="DDI-DrugBank.d99.s23.p0" e1="DDI-DrugBank.d99.s23.e0"
            e2="DDI-DrugBank.d99.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s23.p1" e1="DDI-DrugBank.d99.s23.e0"
            e2="DDI-DrugBank.d99.s23.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d99.s23.p2" e1="DDI-DrugBank.d99.s23.e0"
            e2="DDI-DrugBank.d99.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s23.p3" e1="DDI-DrugBank.d99.s23.e1"
            e2="DDI-DrugBank.d99.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s23.p4" e1="DDI-DrugBank.d99.s23.e1"
            e2="DDI-DrugBank.d99.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s23.p5" e1="DDI-DrugBank.d99.s23.e2"
            e2="DDI-DrugBank.d99.s23.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s24" text="Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.">
        <entity id="DDI-DrugBank.d99.s24.e0" charOffset="19-28"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d99.s24.e1" charOffset="68-92"
            type="drug" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d99.s24.e2" charOffset="98-107"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d99.s24.e3" charOffset="160-174"
            type="drug" text="antidepressants"/>
        <pair id="DDI-DrugBank.d99.s24.p0" e1="DDI-DrugBank.d99.s24.e0"
            e2="DDI-DrugBank.d99.s24.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s24.p1" e1="DDI-DrugBank.d99.s24.e0"
            e2="DDI-DrugBank.d99.s24.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s24.p2" e1="DDI-DrugBank.d99.s24.e0"
            e2="DDI-DrugBank.d99.s24.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s24.p3" e1="DDI-DrugBank.d99.s24.e1"
            e2="DDI-DrugBank.d99.s24.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d99.s24.p4" e1="DDI-DrugBank.d99.s24.e1"
            e2="DDI-DrugBank.d99.s24.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d99.s24.p5" e1="DDI-DrugBank.d99.s24.e2"
            e2="DDI-DrugBank.d99.s24.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s25" text="Caution is advised if patients receive large doses of ethchlorvynol concurrently.">
        <entity id="DDI-DrugBank.d99.s25.e0" charOffset="54-66"
            type="drug" text="ethchlorvynol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d99.s26" text="Transient delirium has been reported in patients who were treated with one gram of ethchlorvynol and 75 - 150 mg of amitriptyline HCl.">
        <entity id="DDI-DrugBank.d99.s26.e0" charOffset="83-95"
            type="drug" text="ethchlorvynol"/>
        <entity id="DDI-DrugBank.d99.s26.e1" charOffset="116-132"
            type="drug" text="amitriptyline HCl"/>
        <pair id="DDI-DrugBank.d99.s26.p0" e1="DDI-DrugBank.d99.s26.e0"
            e2="DDI-DrugBank.d99.s26.e1" ddi="true" type="effect"/>
    </sentence>
</document>
